Immunology in the News

On this page

Immunology Highlights


– News Center

Christopher Garcia is the 2024 Passano Award winner

Garcia was recognized for his research into the way molecules bind to one another and its implications for safer and more effective treatments.


Stanford researchers make critical COVID-19 discovery

After 5 years with COVID-19, health experts say there is still much to learn about the virus that causes the disease. At the height of the pandemic, hospitals were overwhelmed with patients with severe cases of the respiratory virus including life-threatening complications. It was believed that a certain type of lung cell made some people more susceptible to severe infection but now that is no longer the case. KTVU's Heather Holmes speaks with Stanford scientists Catherine Blish and Mark Krasnow about their critical new research that found a different suspected source of vulnerability.

– News Center

Stanford Medicine study flags unexpected cells in lung as suspected source of severe COVID

A previously overlooked type of immune cell allows SARS-CoV-2 to proliferate, Stanford Medicine scientists have found. The discovery has important implications for preventing severe COVID-19.

– Pipelinereview

Tr1X Announces FDA Clearance of First Investigational New Drug Application for TRX103, an Allogeneic Regulatory T-Cell Therapy to Treat Autoimmune Diseases - Pipelinereview

SAN DIEGO, CA, USA I April 10, 2024 I Tr1X, Inc., an autoimmune and inflammatory disease cell therapy company focused on the development of novel

– Bitterroot Star

Collaborative research provides clues to immunity, longer life - Bitterroot Star

by Michael Howell Feeling old and especially vulnerable in the face of the many variations of Flu and RSVP viruses going around? There is good reason to be concerned. Recent […]

– Medscape

Multiple Sclerosis and Epstein-Barr Virus: What Do We Know?

Research suggested that EBV is the primary cause of MS. What are the clinical implications, and could this transform treatment and prevention of this neurodegenerative condition?

– News Center

Old immune systems revitalized in Stanford Medicine mouse study, improving vaccine response

Those with aging immune systems struggle to fight off novel viruses and respond weakly to vaccination. Stanford Medicine researchers were able to revitalize the immune system in mice.

– Ark Invest

The Power Of Fitness Wearables with Stanford’s Dr. Michael Snyder

On this episode of FYI, hosts Nemo Marjanovic and Charles Roberts speak with Professor Dr. Michael Snyder, a leading figure in genomics and personalized medicine.

– Healthier, Happy Lives Blog

Remission Holds Fast After Five Relapses for Young Woman With Leukemia

None of the treatments designed to fight Camille's acute lymphocytic leukemia worked, until an innovative stem cell transplant at Stanford.


Your microbiome contains trillions of bacteria and is unique like your fingerprint

Trillions of bacteria inhabiting our bodies -- collectively known as the microbiome -- are as unique to an individual as their fingerprint.

– The Scientist Magazine®

The Resilience of Monoclonal Antibodies and their Makers

The road to developing monoclonal antibodies for effectively targeting cancer was paved with tenacity, passion, and strokes of luck.

– Nature

CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results - Leukemia

Leukemia - CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results

– Healthier, Happy Lives Blog

Remission Holds Fast After Five Relapses for Young Woman With Leukemia

None of the treatments designed to fight Camille's acute lymphocytic leukemia worked, until an innovative stem cell transplant at Stanford.

– Stanford News

This protein pic could help develop new cancer treatments

A molecular “snapshot” of a protein can be critical to understanding its function. Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer treatments.

– Scope

Unconventional Paths: How she flipped traditional genomics analysis on its head

Statistics expert Julia Salzman returned to biology and has married her two areas of expertise to design a new form of genomics analysis.

– Scope

Going beyond B cells in the search for a more multi-targeted vaccine

The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.

– Scope

Searching for vaccine variability in the land of the flu

The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.

– Scope

The hunt for a vaccine that fends off not just a single viral strain, but a multitude

Stanford Medicine researchers are designing vaccines that might protect people from not merely individual viral strains but broad ranges of them. The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.

– Nature

Discovery of sparse, reliable omic biomarkers with Stabl

Stabl selects sparse and reliable biomarker candidates from predictive models.



  • – News Center

    New blood test to identify infections could reduce global antibiotic overuse

    A diagnostic test developed by Stanford Medicine scientists can separate bacterial and viral infections with 90% accuracy, the first to meet standards set by the World Health Organization. The new test is described in a paper published Dec. 20 in Cell Reports Medicine. “Antimicrobial resistance is continuously rising, so there has been a lot of effort to reduce inappropriate antibiotic usage,” said Purvesh Khatri, PhD, associate professor of medicine and biomedical data science, and the senior author of the paper. “Accurately diagnosing whether a patient has a bacterial or viral infection is one of the biggest global health challenges.”

  • – News Center

    Researchers may have found a new path for halting cancer cell production

    After finding long, repetitive sequences in the genomes of seven kinds of cancer, researchers at Stanford Medicine and their colleagues developed a molecule that curbed their production. Although the scientists aren’t sure what role the repetitive sequences play in cancer, they were encouraged that they appeared to have found a way to inhibit the creation of more cancer cells. “The most dramatic result was that you could actually target them and stop cell proliferation,” said Michael Snyder, PhD, professor and chair of the department of genetics.

  • – Human Performance Alliance

    Speeding up bone healing in menopausal females

    lder women heal bone fractures slower than men. Now a team has found that a single, localized delivery of estrogen to a fracture can speed up healing in postmenopausal mice. The findings could have implications for the way fractures in women are treated in the future. “The majority of stem cell research is done on male animals. There’s very little research that has actually been done on females,” said Wu Tsai Alliance member Charles Chan, PhD, an assistant professor of surgery at Stanford University and co-senior author of the paper published Oct. 30 in Nature Communications. “The research is long overdue, especially the question of why women heal differently from men.”

  • – Pharmacy Times

    Expert: Immune Reconstitution With Orca-T Reveals ‘New Realm of Engineered Donor Grafts’ for Patients With Hematologic Malignancies

    Pharmacy Times interviewed Everett Meyer, MD, PhD, medical and scientific director of the Cellular Therapy Facility, Stanford Health Care and Assistant Professor of Medicine, Blood and Marrow Transplantation, Stanford University, on the poster presentation titled “Rapid Immune Reconstitution and Elevated Regulatory T Cell Frequencies in Patients Treated with Orca-T” at the 64th American Society of Hematology (ASH) Annual Meeting and Exhibition in New Orleans, Louisiana.

  • – Helio

    Stanford researcher receives award for lifetime achievement in hematology

    Irving Weissman, MD, will receive the Wallace H. Coulter Award for Lifetime Achievement in Hematology at this year’s ASH Annual Meeting & Exposition. Weissman, director of Stanford Medicine’s Institute for Stem Cell Biology and Regenerative Medicine, has made several important contributions to hematology over the past 5 decades.


  • – Scope

    Who's on first? Duking out scientific paper authorship order

    Determining the order of authors on a scientific paper can be tricky. Unless you're a pair of video gaming graduate students. Recently Stanford researcher Garry Nolan, PhD, tweeted about an unconventional way two researchers in his laboratory who had each contributed equally to a study decided who should be listed first on the print version of the paper.

  • – BBC

    BBC Radio 5 live - 5 Live Science Podcast, Life in plastic, is it fantastic?

    As the government moves to Plan B - what actually happens when you catch the new variant?

  • – Stanford Professor Garry Nolan Is Analyzing Anomalous Materials From UFO Crashes

    Stanford Professor Garry Nolan Is Analyzing Anomalous Materials From UFO Crashes

    A Q&A with one of the foremost scientists studying UAPs, and what he hopes to learn by systematically studying bizarre and difficult-to-explain incidents. Dr. Garry Nolan is a Professor of Pathology at Stanford University. His research ranges from cancer to systems immunology. Dr. Garry Nolan has also spent the last ten years working with a number of individual analyzing materials from alleged Unidentified Aerial Phenomenon.

  • – Gizmodo

    The Coronavirus Can Infect and Possibly Hide in Fat Cells, Study Finds

    The preliminary findings could partially explain why people living with obesity are at higher risk of severe covid-19. “This could well be contributing to severe disease,” senior author, Catherine Blish, an immunologist at the Stanford University School of Medicine, told the New York Times. “We’re seeing the same inflammatory cytokines that I see in the blood of the really sick patients being produced in response to infection of those tissues.”

  • – Mail Online

    Blood from ultra-fit mice 'could hold the key to staving off dementia'

    Injections of blood from young adult mice that are getting lots of exercise benefited the brains of sedentary mice the same age, according to a study by the Stanford School of Medicine in California. 'The discovery could open the door to treatments that, by taming brain inflammation in people who don't get much exercise, lower their risk of neurodegenerative disease or slow its progression,' said Professor Tony Wyss-Coray, of the Stanford School of Medicine in California, which carried out the research.

October 7, 2021 - The Edge
How can technology help you track real time data about your health and wellbeing? And why should you track anyway? In this episode, Michael Snyder, professor of genetics, talks about how tracking can help you gain deeper understanding of what is going on in your body at a physiological level. Often, illnesses begin developing in our bodies quietly, before any symptoms begin to show up. Snyder’s research shows that by tracking on a regular basis, we can pre-empt diseases. Health data collection using wearable tech can help us take a proactive approach toward prevention of disease. And like they say, prevention is better than cure.

  • – Scope

    What to do (and not do) when you win the Nobel Prize

    Three of Stanford Medicine's Nobel laureates, including Andrew Fire, George D. Smith Professor of Molecular and Genetic Medicine and Professor of Pathology and of Genetics, offer advice to future winners about hearing the news and what to expect next in their careers.

  • – The Scientist Magazine

    When the Immune Response Makes COVID-19 Worse

    If the immune system makes mistake--reacting late or getting the target wrong--it can amplify the damage wrought by SARS-CoV-2.

  • – News Center

    Statins may be effective treatment for patients with ulcerative colitis

    People with ulcerative colitis who are also taking statins have about a 50% decreased risk of colectomies and hospitalization, according to a Stanford Medicine study. Purvesh Khatri, PhD, associate professor of medicine and of biomedical data science, and his team tracked down a connection between a handful of drugs and decreased symptoms of ulcerative colitis.

  • – Business Insider

    Why Stanford is spending millions to incorporate Apple Watches and Fitbits into medical care

    Stanford is exploring consumer wearable devices, including Apple Watches and Fitbits, to monitor heart rates and predict COVID-19 symptoms. Michael Snyder, professor of genetics, leads many of the health systems' wearable projects and says it's up to health systems to quickly figure out whether the data's useful to doctors and how to efficiently extract it from the devices.

  • – Scope

    Blood test predicts chances of lymphoma relapse after therapy

    Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.To understand whether ctDNA tracking might hint at relapse, Miklos, who heads Stanford Medicine's Blood and Marrow Transplantation and Cellular Therapy division, Matthew Frank MD, PhD assistant professor of medicine, and their labs enrolled 72 patients with large B-cell lymphoma, who had received CAR-T cell therapy, which involves genetically engineering certain immune cells to find and eliminate specific cancer cells.

June 23, 2021 – NBC Bay Area

NBC Bay Area: COVID-19 and brain inflammation

Stanford researchers have found signs of inflammation, genetic changes and impaired circuitry in the brains of people killed by COVID-19, important clues to the mysterious “brain fog” and mental struggles reported by many patients. Tony Wyss-Coray, professor of neurology and neurological sciences at Stanford Medicine provides comments.

  • – MarketWatch

    How COVID vaccine's mRNA technology could help cure other diseases

    Scientists and companies are trying to harness the mRNA technology to develop vaccines against cancer and other diseases. Bali Pulendran, Violetta L. Horton Professor And Professor Of Microbiology And Immunology and of Pathology, comments on the future on vaccines.

  • – News Center

    Stanford researchers find signs of inflammation in brains of people who died of COVID-19

    A detailed molecular analysis of tissue from the brains of individuals who died of COVID-19 reveals extensive signs of inflammation and neurodegeneration, but no sign of the virus that causes the disease. Tony Wyss-Coray, PhD, professor of neurology and neurological sciences at Stanford, shares senior authorship with Andreas Keller, PhD, chair of clinical bioinformatics at Saarland University.

  • – News Center

    Climate change linked to longer allergy season in Bay Area, Stanford study finds

    Air levels of pollen and mold spores in the San Francisco Bay Area are elevated for about two more months per year than in past decades, and higher temperatures are to blame, a Stanford Medicine study has found, led by senior author, Kari Nadeau, MD, PhD, professor of medicine and of pediatrics at Stanford School of Medicine.

  • – Stanford Today

    Faculty Women’s Forum announces 2021 award winners

    The 2021 Faculty Women’s Forum Awards honor individuals for their outstanding work supporting women at Stanford through role modeling, allyship, leadership and sponsorship. Stanford Immunology faculty Dr. Joy Wu, an associate professor of medicine (endocrinology, gerontology and metabolism) in the School of Medicine is honored in the Allyship Award category.

  • – News Center

    Smartwatch data can predict blood test results, study reports

    Stanford researchers found that data from smartwatches can flag early signs of some health conditions and predict the results of simple blood tests. Scientists from the lab of Michael Snyder, PhD, professor and chair of genetics, tracked data from smartwatches, blood tests and other tests conducted in a doctor’s office in a small group of study participants.